Mucosal vaccination protects mice against influenza A heterosubtypic challenge

International Congress Series

Volumn 1219, Issue C, 2001, Pages 985-992

  Tumpey, T M ^a   Clements, J D ^b,c   Katz, J M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Influenza H5N1; Mouse model; Vaccines

Indexed keywords

EID: 0442273115     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00653-7     Document Type: Article

References (15)

1. Webster, R.G., Bean, W.J., Gorman, O.T., Chambers, T.M., Kawaoka, Y., Evolution and ecology of influenza A viruses. Microbiol. Rev., 56, 1992, 152.
2. Claas, E.C., Osterhaus, A.D., van Beek, R., de Jong, J.C., Rimmelzwaan, G.F., Senne, D.A., Krauss, S., Shortridge, K.F., Webster, R.G., Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351 (1998), 472–477.
3. Subbarao, K., Klimov, A., Katz, J.M., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., Hemphill, M., Rowe, T., Shaw, M., Xu, X., Fukuda, K., Cox, N., Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 (1998), 393–396.
4. Yuen, K.Y., Chan, P.K., Peiris, M., Tsang, D.N., Que, D.L., Shortridge, K.F., Cheung, P.T., To, W.K., Ho, E.T., Sung, R., Cheng, A.F., Members of the H5N1 study group. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351 (1999), 467–471.
5. 2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158 (1997), 1222–1230.
6. Liang, S., Mozdzanowska, K., Pallandino, G., Gerhard, W., Heterosubtypic immunity to influenza type A virus in mice. J. Immunol. 152 (1994), 1653–1661.
7. Nguyen, H.H., Moldoveanu, Z., Novak, M.J., van Ginkel, F.W., Ban, E., Kiyono, H., McGhee, J.R., Mestecky, J., Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 254 (1999), 50–60.
8. Lu, X.T., Tumpey, T.M., Morken, T., Zaki, S., Cox, N.J., Katz, J.M., A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) virus isolated from humans. J. Virol. 73 (1999), 5903–5911.
9. Reed, L.J., Muench, H., A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938), 493–497.
10. Cox, N.J., Kendal, A.P., Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J. Infect. Dis. 149 (1984), 194–200.
11. Dickinson, B.L., Clements, J.D., Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity form ADP-ribosyltransferase activity. Infect. Immun. 63 (1995), 1617–1623.
12. Katz, J.M., Lu, X., Young, S.A., Galphin, J.C., Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J. Infect. Dis. 175 (1997), 352–363.
13. Gao, P.S., Watanabe, S., Ito, T., Goto, H., Wells, K., McGregor, M., Cooley, A.J., Kawaoka, Y., Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol. 73 (1999), 3184–3189.
14. Tumpey, T.M., Lu, X., Morken, T., Zaki, S.R., Katz, J.M., Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 74 (2000), 6105–6116.
15. Oplinger, M.L., Baqar, S., Trofa, A.F., Clements, J.D., Gibbs, P., Pazzaglia, G., Bourgeois, A.L., Scott, D.A., Safety and immunogenicity in volunteers of a new candidate oral mucosal adjuvant, LT(R192G). abstr. G-10 Program and Abstracts of the 37th Interscience Conference on Antimirobial Agents and Chemotherapy, 1997, 193.